MAZIBRADA, Jasenka
 Distribuzione geografica
Continente #
EU - Europa 312
NA - Nord America 310
AS - Asia 161
SA - Sud America 6
OC - Oceania 5
AF - Africa 1
Totale 795
Nazione #
US - Stati Uniti d'America 295
DE - Germania 140
CN - Cina 83
IT - Italia 75
RU - Federazione Russa 22
JP - Giappone 17
GB - Regno Unito 14
VN - Vietnam 14
CZ - Repubblica Ceca 13
IN - India 12
TW - Taiwan 10
CA - Canada 9
KR - Corea 8
PL - Polonia 8
SE - Svezia 7
IE - Irlanda 6
MX - Messico 6
NL - Olanda 6
SG - Singapore 6
AU - Australia 5
BE - Belgio 5
BR - Brasile 4
HK - Hong Kong 3
HR - Croazia 3
DK - Danimarca 2
FR - Francia 2
PK - Pakistan 2
RS - Serbia 2
TH - Thailandia 2
UA - Ucraina 2
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LV - Lettonia 1
NP - Nepal 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 795
Città #
Torino 43
Beijing 38
Fairfield 33
Houston 32
Ashburn 19
Woodbridge 18
Ann Arbor 16
Seattle 16
Nürnberg 13
Dong Ket 12
Santa Cruz 12
Wilmington 12
University Park 10
Buffalo 8
Pisa 8
Shanghai 8
Taipei 8
Warsaw 8
Cambridge 7
Dublin 6
Leawood 6
Wuhan 6
Guangzhou 5
Saga 5
Singapore 5
Charlottesville 4
Mountain View 4
Penza 4
Utrecht 4
Bengaluru 3
Chengdu 3
Henderson 3
Las Vegas 3
Los Angeles 3
Milan 3
Ottawa 3
Phoenix 3
Annapolis 2
Baltimore 2
Berlin 2
Boardman 2
Bottrop 2
Council Bluffs 2
Garza García 2
Harbin 2
Napoli 2
New Delhi 2
New York 2
Padova 2
Portland 2
Riva 2
Rome 2
Suita 2
Tokyo 2
Tucson 2
Allahabad 1
Atlanta 1
Austin 1
Bangkok 1
Bear 1
Belgrade 1
Bhojpur 1
Boston 1
Bothell 1
Brisbane 1
Brussels 1
Budapest 1
Catania 1
Central 1
Central District 1
Chandler 1
Cluj-napoca 1
Denver 1
Dhaka 1
Dresden 1
Duarte 1
Edinburgh 1
Edmonton 1
Enfield 1
Essen 1
Florence 1
Hamburg 1
Hangzhou 1
Heidelberg 1
Iksan 1
La Paz 1
Lexington 1
Liverpool 1
London 1
Mainz 1
Markham 1
Mcallen 1
Mons 1
Montréal 1
Munich 1
Nanchang 1
Ningbo 1
Odessa 1
Ohain 1
Paris 1
Totale 475
Nome #
The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps., file e27ce428-395e-2581-e053-d805fe0acbaa 256
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis, file e27ce426-f532-2581-e053-d805fe0acbaa 146
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. M. DE ANDREA CO-FIRST AUTHOR, file e27ce426-b43a-2581-e053-d805fe0acbaa 141
Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: Expression and prognostic significance, file e27ce42d-ca6b-2581-e053-d805fe0acbaa 93
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. M. DE ANDREA CO-FIRST AUTHOR, file e27ce426-cf66-2581-e053-d805fe0acbaa 80
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer, file e27ce426-e2c2-2581-e053-d805fe0acbaa 73
Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression., file e27ce426-f400-2581-e053-d805fe0acbaa 26
Targeting PAD-mediated citrullination to treat human papillomavirus infections, file e27ce432-b88f-2581-e053-d805fe0acbaa 16
Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression., file e27ce431-81f9-2581-e053-d805fe0acbaa 10
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. M. DE ANDREA CO-FIRST AUTHOR, file e27ce426-cf65-2581-e053-d805fe0acbaa 2
Plexiform schwannoma of the posterior pharyngeal wall in a patient with neurofibromatosis 2, file e27ce429-5593-2581-e053-d805fe0acbaa 2
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. M. DE ANDREA CO-FIRST AUTHOR, file e27ce426-b439-2581-e053-d805fe0acbaa 1
Totale 846
Categoria #
all - tutte 1046
article - articoli 0
book - libri 0
conference - conferenze 40
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201827 0000 00 00 35145
2018/201987 3243 53 316 692211
2019/2020139 2213612 410 922 1210127
2020/2021131 813109 616 103 16161113
2021/2022186 208826 2319 96 18152212
2022/202380 861913 87 510 4000
Totale 846